The Upper Tribunal has handed HMRC an important victory in its long-running dispute with Align Technology over the VAT treatment of Invisalign clear aligners.
The decision concludes that Invisalign aligners are not “dental prostheses” for VAT purposes and therefore do not qualify for the VAT exemption available to certain dental supplies. Instead, they are subject to VAT at the standard rate.
While the case focuses on clear aligners, its significance extends far beyond Invisalign. The decision provides a reminder that VAT exemptions in the healthcare sector are often narrower than businesses expect and that innovative products can struggle to fit within legislative concepts drafted many years before those products existed.
Why should businesses care?
The immediate impact falls on manufacturers, distributors and suppliers of orthodontic devices. However, the wider message is relevant to any business supplying healthcare products that sit somewhere between a traditional medical device and a course of treatment.
The Tribunal accepted that aligners are bespoke products, manufactured specifically for individual patients and used to address functional dental issues. Nevertheless, it concluded that this was not enough to secure VAT exemption because the legislation exempts only the supply of “dental prostheses”, not all products used in dental treatment.
For businesses, this reinforces a key VAT principle: the clinical purpose of a product does not determine its VAT treatment. The starting point remains the precise wording of the legislation.
The real takeaway: function matters
The Tribunal drew a distinction between products that replace teeth and those that move or correct them.
In its view, a dental prosthesis is something that replaces missing or damaged teeth, such as a crown, bridge or denture. Aligners, by contrast, are orthodontic devices designed to reposition existing teeth as part of treatment. As they do not replace teeth, they fall outside the exemption.
That distinction may have implications well beyond clear aligners. As healthcare technology continues to evolve, businesses increasingly market products that restore functionality, support treatment or improve patient outcomes without replacing a body part in the traditional sense. This decision suggests that HMRC and the courts will continue to focus closely on what a product actually does when determining whether an exemption applies.
Areas businesses should review
Although the decision relates specifically to Invisalign aligners, it may be worth reviewing whether any products currently treated as exempt rely on a similarly broad interpretation of healthcare exemptions.
Questions businesses may want to consider include:
- Are any products currently being treated as exempt because they are regarded as prosthetic or restorative?
- Does the product genuinely replace a missing or damaged body part, or is it better characterised as a treatment device?
- Has the VAT analysis kept pace with product innovation and technological developments?
- Are contractual arrangements sufficiently robust to deal with a change in VAT treatment?
- Could there be any historic VAT exposure if HMRC were to challenge the existing treatment?
These questions are particularly relevant for dental technology businesses, medical device manufacturers and healthcare groups operating in areas where products do not fit neatly into established VAT categories.
A broader trend
The decision is also consistent with a broader trend in VAT disputes. HMRC has increasingly focused on the exact statutory wording of exemptions and reliefs, particularly where new technologies seek to rely on concepts developed for more traditional products and services.
Businesses introducing innovative healthcare products should therefore be cautious about assuming that a favourable clinical outcome automatically translates into favourable VAT treatment. The analysis will generally turn on the legislative language rather than the commercial or medical benefits of the product.
What happens next?
Align may seek permission to appeal, so this may not be the final word. For now, however, the Upper Tribunal has provided a clear indication of how HMRC is likely to approach orthodontic aligners and similar products.
For businesses operating in the dental and healthcare sectors, the case serves as a useful prompt to revisit VAT positions that may have been adopted many years ago and to ensure they remain sustainable in light of current products, technology and case law.
The key lesson is a simple one: a product may be bespoke, medically necessary and supplied as part of patient care, but that will not bring it within a VAT exemption unless it falls squarely within the wording of the legislation.
